You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 5, May 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 69TH ANNUAL MEETING OF THE NEW ENGLAND SURGICAL SOCIETY, MONTREAL, CANADA, SEPT 15 TO SEPT 17, 1988
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Progress in Experimental Porcine Small-Bowel Transplantation

Hironori Kaneko, MD; Wayne Hancock, MD, PhD; Robert T. Schweizer, MD

Arch Surg. 1989;124(5):587-592.


Abstract

• Studies in large animals are needed to overcome technical complications, allograft rejection, and graft-vs-host disease, which are major problems that prevent clinical application of small-bowel transplantation. The small bowel was allografted heterotopically or orthotopically into 30 pigs with the use of cyclosporine, prednisone, and azathioprine. When cyclosporine was given orally to heterotopically transplantation recipients, rejection was frequent, and graft-vs-host disease caused one death. After 30 days of intravenous cyclosporine followed by oral administration, no rejection occurred. Graft-vs-host disease was mild or absent, and there were some long-term survivors. Technical failures were relatively infrequent, but death from sepsis, eg, intra-abdominal abscess, occurred in 17% (5/30). Anastomoses of donor superior mesenteric vein to recipient portal vein offered no advantages over systemic venous drainage. Although the high cyclosporine levels used would be intolerable in humans, these results indicate that successful small-bowel transplantation can be achieved with adequate immunosuppression in a large animal.

(Arch Surg. 1989;124:587-592)



Author Affiliations

From the Surgical Research Laboratory (Drs Kaneko, Hancock, and Schweizer) and Transplantation Service (Drs Kaneko, Hancock, and Schweizer), Department of Surgery, Hartford (Conn) Hospital, and the University of Connecticut School of Medicine (Drs Hancock and Schweizer), Farmington.


Footnotes

Accepted for publication December 9, 1988.

Read before the 69th Annual Meeting of the New England Surgical Society, Montreal, Canada, September 16, 1988.

Reprint requests to Transplantation Service, Department of Surgery, Hartford Hospital, Hartford, CT 06115 (Dr Kaneko).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.